Amanote Research

Amanote Research

    RegisterSign In

Cd19

doi 10.1007/978-3-662-49054-9_688-1
Full Text
Open PDF
Abstract

Available in full text

Date

January 1, 2017

Authors
H. RenzB. Gierten
Publisher

Springer Berlin Heidelberg


Related search

Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins

English

CD19 Affinity — Is Lower Also Better?

Nature Reviews Clinical Oncology
Oncology
2019English

Axicabtagene Ciloleucel for CD19+ Plasmablastic Lymphoma

American Journal of Hematology
Hematology
2019English

Toxicities of CD19 CAR-T Cell Immunotherapy

American Journal of Hematology
Hematology
2019English

CD19+CD5+ Cells as Indicators of Preeclampsia

Hypertension
Internal Medicine
2012English

CD19-Targeted T Cells for Hematologic Malignancies

Cancer Journal
Cancer ResearchOncology
2015English

169. Clinically Adaptable CD19-Specific Chimeric Antigen Receptor

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

CAR-T Cells Beyond CD19, UnCAR-Ted Territory

American Journal of Hematology
Hematology
2019English

Synergistic Antitumor Effect of Bispecific CD19 X CD3 and CD19 X CD16 Diabodies in a Preclinical Model of Non-Hodgkin's Lymphoma

Journal of Immunology
AllergyImmunology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy